派林生物：公司截至三季度末采浆量近1200吨，同比增长约10%

Group 1 - The company reported a total plasma collection of nearly 1,200 tons by the end of Q3, representing a year-on-year increase of approximately 10% [2] - The growth in plasma collection volume is considered to be favorable compared to the previous year [2] - The company is inquired about its ability to meet the annual plasma collection target for the year [2] Group 2 - Specific plasma collection figures for competitors, including Shuanglin, Paisfeike, and Xinjiang Deyuan, were requested by investors [2] - The company acknowledged the inquiry and provided its own plasma collection data without disclosing competitors' figures [2] - The interaction took place on an investor communication platform, indicating active engagement with stakeholders [2]